Logo image of CZR

CAESARS ENTERTAINMENT INC (CZR) Stock Fundamental Analysis

NASDAQ:CZR - Nasdaq - US12769G1004 - Common Stock - Currency: USD

29.83  -1.01 (-3.27%)

After market: 29.8 -0.03 (-0.1%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CZR. CZR was compared to 132 industry peers in the Hotels, Restaurants & Leisure industry. CZR has a bad profitability rating. Also its financial health evaluation is rather negative. CZR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CZR had negative earnings in the past year.
CZR had a positive operating cash flow in the past year.
CZR had negative earnings in 4 of the past 5 years.
Of the past 5 years CZR 4 years had a positive operating cash flow.
CZR Yearly Net Income VS EBIT VS OCF VS FCFCZR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

The Return On Assets of CZR (-0.73%) is worse than 66.67% of its industry peers.
The Return On Equity of CZR (-5.80%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 5.94%, CZR perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
CZR had an Average Return On Invested Capital over the past 3 years of 5.76%. This is significantly below the industry average of 13.91%.
The 3 year average ROIC (5.76%) for CZR is below the current ROIC(5.94%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.73%
ROE -5.8%
ROIC 5.94%
ROA(3y)-0.39%
ROA(5y)-1.74%
ROE(3y)-4.54%
ROE(5y)-14.28%
ROIC(3y)5.76%
ROIC(5y)4.32%
CZR Yearly ROA, ROE, ROICCZR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

CZR has a better Operating Margin (20.13%) than 78.79% of its industry peers.
In the last couple of years the Operating Margin of CZR has grown nicely.
Looking at the Gross Margin, with a value of 48.96%, CZR is in line with its industry, outperforming 53.79% of the companies in the same industry.
In the last couple of years the Gross Margin of CZR has remained more or less at the same level.
Industry RankSector Rank
OM 20.13%
PM (TTM) N/A
GM 48.96%
OM growth 3Y4.31%
OM growth 5Y2.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y-0.56%
CZR Yearly Profit, Operating, Gross MarginsCZR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CZR is still creating some value.
CZR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CZR has more shares outstanding
Compared to 1 year ago, CZR has a worse debt to assets ratio.
CZR Yearly Shares OutstandingCZR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CZR Yearly Total Debt VS Total AssetsCZR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 0.58, we must say that CZR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CZR (0.58) is worse than 73.48% of its industry peers.
A Debt/Equity ratio of 6.16 is on the high side and indicates that CZR has dependencies on debt financing.
With a Debt to Equity ratio value of 6.16, CZR is not doing good in the industry: 64.39% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 6.16
Debt/FCF N/A
Altman-Z 0.58
ROIC/WACC1.02
WACC5.84%
CZR Yearly LT Debt VS Equity VS FCFCZR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

CZR has a Current Ratio of 0.84. This is a bad value and indicates that CZR is not financially healthy enough and could expect problems in meeting its short term obligations.
CZR's Current ratio of 0.84 is in line compared to the rest of the industry. CZR outperforms 45.45% of its industry peers.
A Quick Ratio of 0.82 indicates that CZR may have some problems paying its short term obligations.
CZR has a Quick ratio (0.82) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.82
CZR Yearly Current Assets VS Current LiabilitesCZR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

4

3. Growth

3.1 Past

CZR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.93%, which is quite impressive.
The Revenue has decreased by -1.25% in the past year.
Measured over the past years, CZR shows a very strong growth in Revenue. The Revenue has been growing by 34.78% on average per year.
EPS 1Y (TTM)32.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.03%
Revenue 1Y (TTM)-1.25%
Revenue growth 3Y5.52%
Revenue growth 5Y34.78%
Sales Q2Q%1.9%

3.2 Future

The Earnings Per Share is expected to grow by 55.94% on average over the next years. This is a very strong growth
Based on estimates for the next years, CZR will show a small growth in Revenue. The Revenue will grow by 3.73% on average per year.
EPS Next Y111.87%
EPS Next 2Y81.46%
EPS Next 3Y51.56%
EPS Next 5Y55.94%
Revenue Next Year2.07%
Revenue Next 2Y2.27%
Revenue Next 3Y2.28%
Revenue Next 5Y3.73%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CZR Yearly Revenue VS EstimatesCZR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B
CZR Yearly EPS VS EstimatesCZR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 -5 -10

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

CZR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 31.18 indicates a quite expensive valuation of CZR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CZR is on the same level as its industry peers.
CZR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 35.33.
Industry RankSector Rank
PE N/A
Fwd PE 31.18
CZR Price Earnings VS Forward Price EarningsCZR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

80.30% of the companies in the same industry are more expensive than CZR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.44
CZR Per share dataCZR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

CZR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CZR's earnings are expected to grow with 51.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y81.46%
EPS Next 3Y51.56%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CZR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAESARS ENTERTAINMENT INC

NASDAQ:CZR (7/15/2025, 8:00:00 PM)

After market: 29.8 -0.03 (-0.1%)

29.83

-1.01 (-3.27%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners111.28%
Inst Owner Change0%
Ins Owners0.93%
Ins Owner Change2.58%
Market Cap6.20B
Analysts80
Price Target43.52 (45.89%)
Short Float %11.48%
Short Ratio4.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-23.27%
Min EPS beat(2)-183.48%
Max EPS beat(2)136.94%
EPS beat(4)1
Avg EPS beat(4)-73.75%
Min EPS beat(4)-183.48%
Max EPS beat(4)136.94%
EPS beat(8)2
Avg EPS beat(8)-299.54%
EPS beat(12)3
Avg EPS beat(12)-1076.58%
EPS beat(16)4
Avg EPS beat(16)-834.87%
Revenue beat(2)0
Avg Revenue beat(2)-1.22%
Min Revenue beat(2)-1.58%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.92%
Min Revenue beat(4)-2.68%
Max Revenue beat(4)-0.85%
Revenue beat(8)1
Avg Revenue beat(8)-1.66%
Revenue beat(12)4
Avg Revenue beat(12)-0.8%
Revenue beat(16)6
Avg Revenue beat(16)-0.46%
PT rev (1m)-0.16%
PT rev (3m)-10.36%
EPS NQ rev (1m)-48.25%
EPS NQ rev (3m)-74.85%
EPS NY rev (1m)-85.43%
EPS NY rev (3m)-91.47%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)-1.74%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-1.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 31.18
P/S 0.55
P/FCF N/A
P/OCF 5.11
P/B 1.53
P/tB N/A
EV/EBITDA 8.44
EPS(TTM)-0.55
EYN/A
EPS(NY)0.96
Fwd EY3.21%
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)5.83
OCFY19.55%
SpS54.32
BVpS19.49
TBVpS-51.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.73%
ROE -5.8%
ROCE 7.51%
ROIC 5.94%
ROICexc 6.12%
ROICexgc 12.24%
OM 20.13%
PM (TTM) N/A
GM 48.96%
FCFM N/A
ROA(3y)-0.39%
ROA(5y)-1.74%
ROE(3y)-4.54%
ROE(5y)-14.28%
ROIC(3y)5.76%
ROIC(5y)4.32%
ROICexc(3y)5.94%
ROICexc(5y)4.47%
ROICexgc(3y)12.3%
ROICexgc(5y)9.19%
ROCE(3y)7.29%
ROCE(5y)5.47%
ROICexcg growth 3Y12.39%
ROICexcg growth 5Y-1.47%
ROICexc growth 3Y12.76%
ROICexc growth 5Y-4.07%
OM growth 3Y4.31%
OM growth 5Y2.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y-0.56%
F-Score4
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 6.16
Debt/FCF N/A
Debt/EBITDA 6.89
Cap/Depr 93.8%
Cap/Sales 11.24%
Interest Coverage 3.76
Cash Conversion 33.43%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.82
Altman-Z 0.58
F-Score4
WACC5.84%
ROIC/WACC1.02
Cap/Depr(3y)93.85%
Cap/Depr(5y)77.92%
Cap/Sales(3y)10.59%
Cap/Sales(5y)9.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.03%
EPS Next Y111.87%
EPS Next 2Y81.46%
EPS Next 3Y51.56%
EPS Next 5Y55.94%
Revenue 1Y (TTM)-1.25%
Revenue growth 3Y5.52%
Revenue growth 5Y34.78%
Sales Q2Q%1.9%
Revenue Next Year2.07%
Revenue Next 2Y2.27%
Revenue Next 3Y2.28%
Revenue Next 5Y3.73%
EBIT growth 1Y-6.27%
EBIT growth 3Y10.07%
EBIT growth 5Y38.4%
EBIT Next Year70.2%
EBIT Next 3Y22.66%
EBIT Next 5Y16.6%
FCF growth 1Y-114.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.85%
OCF growth 3Y-3.11%
OCF growth 5Y28.03%